Craneware plc (AIM:CRW)
London · Delayed Price · Currency is GBP · Price in GBX 1,496.00
+26.00 (1.77%)
Apr 16, 2026, 5:06 PM GMT
Craneware Market Cap
Craneware has a market cap or net worth of 518.25 million as of April 16, 2026. Its market cap has decreased by -16.86% in one year.
Market Cap
518.25M
Enterprise Value
507.82M
Revenue
157.02M
Ranking
n/a
PE Ratio
32.06
Stock Price
1,496.00
Market Cap Chart
Since September 13, 2007, Craneware's market cap has increased from 27.00M to 518.25M, an increase of 1,819.78%. That is a compound annual growth rate of 17.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 509.24M | -24.77% |
| Dec 31, 2025 | 676.88M | -8.39% |
| Dec 31, 2024 | 738.88M | 20.69% |
| Dec 29, 2023 | 612.23M | -3.93% |
| Dec 30, 2022 | 637.29M | -26.03% |
| Dec 31, 2021 | 861.52M | 41.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.02B |
| GSK plc | 85.13B |
| Haleon | 31.48B |
| Smith & Nephew | 10.78B |
| CVS Group | 848.19M |
| Oxford Biomedica | 750.79M |
| Allergy Therapeutics | 690.25M |
| Spire Healthcare Group | 638.55M |